Results 241 to 250 of about 125,200 (262)

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

Circulation, 2012
Marco Valgimigli, Gianluca Campo, Pascal Vranckx   +2 more
exaly  

Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents

Circulation, 2009
KRISTIAN B Filion
exaly  

Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy

Trends in Pharmacological Sciences, 2017
Benjamin E Tourdot, Michael Holinstat
exaly  

Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma

Cancers, 2020
Tsuguru Hayashi, Yuichi Honma, Masaru Harada   +2 more
exaly  

Bioactive peptides and proteins as alternative antiplatelet drugs

Medicinal Research Reviews, 2019
Kannan R R Rengasamy, Haroon Khan, Imad Ahmad   +2 more
exaly  

Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone

Bioresource Technology, 2006
Hoi-Seon Lee
exaly  

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

Lancet, The, 2007
Lisa M Askie, Lelia Duley, Lesley A Stewart   +2 more
exaly  

Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack

Circulation, 2013
Ka Sing Wong, Yongjun Wang, Xinyi Leng
exaly  

Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation

Circulation, 2010
Salvatore Brugaletta, Manel Sabate, JOSÉ M De La Torre   +2 more
exaly  

Antiplatelet Therapy as a Risk Factor for Microbleeds in Intracerebral Hemorrhage Patients: Analysis Using Specific Antiplatelet Agents

Journal of Stroke and Cerebrovascular Diseases, 2013
Shinichi Wakabayashi, Masayasu Matsumoto   +1 more
exaly